Bradley Foster & Sargent’s iShares Biotechnology ETF IBB Stock Holding History

Bradley Foster & Sargent’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Hold	9,175	–	–	0.02%	253
2026 Q1	$1.55M	Hold	9,175	–	–	0.02%	253
2025 Q4	$1.55M	Hold	9,175	–	–	0.02%	248
2025 Q3	$1.32M	Hold	9,175	–	–	0.02%	260
2025 Q2	$1.16M	Sell	9,175 -637	-6%	-$78.2K	0.02%	274
2025 Q1	$1.25M	Sell	9,812 -600	-6%	-$81.4K	0.02%	249
2024 Q4	$1.38M	Sell	10,412 -250	-2%	-$35.1K	0.02%	245
2024 Q3	$1.55M	Sell	10,662 -130	-1%	-$18.8K	0.03%	233
2024 Q2	$1.48M	Buy	10,792 +492	+5%	+$65.7K	0.03%	228
2024 Q1	$1.41M	Hold	10,300	–	–	0.03%	235
2023 Q4	$1.4M	Sell	10,300 -85	-0.8%	-$10.4K	0.03%	240
2023 Q3	$1.32M	Hold	10,385	–	–	0.03%	248
2023 Q2	$1.32M	Hold	10,385	–	–	0.03%	248
2023 Q1	$1.34M	Sell	10,385 -50	-0.5%	-$6.54K	0.03%	222
2022 Q4	$1.37M	Buy	10,435 +495	+5%	+$64K	0.03%	216
2022 Q3	$1.16M	Hold	9,940	–	–	0.03%	212
2022 Q2	$1.17M	Sell	9,940 -179	-2%	-$21.2K	0.03%	223
2022 Q1	$1.32M	Buy	10,119 +6,804	+205%	+$886K	0.03%	239
2021 Q4	$506K	Buy	+3,315	New	+$513K	0.01%	325

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Bradley Foster & Sargent's IBB Position: Q2 2026 in Review

Bradley Foster & Sargent held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 9,175 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #253.

Bradley Foster & Sargent first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Bradley Foster & Sargent held 9,175 shares of iShares Biotechnology ETF worth $1.74M as of Q2 2026.
Bradley Foster & Sargent left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.02% of Bradley Foster & Sargent's portfolio in Q2 2026, its #253 holding.
Bradley Foster & Sargent first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.